Compare Oklo Inc (OKLO) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oklo Inc vs Smith & Nephew plc — how do they compare? Oklo Inc trades at $42.39 (market cap $7.92B), while Smith & Nephew plc trades at $27.96 (market cap $11.62B). The key difference: Smith & Nephew plc is the larger of the two by market cap, and Smith & Nephew plc pays a 2.86% dividend while Oklo Inc pays none. Which is the better fit depends on your goals.
| OKLO | SNN | |
|---|---|---|
Market Cap | $7.92B | $11.62B |
Sector | Technology | Health |
52-Week High | $174.14 | $38.53 |
52-Week Low | $36.84 | $27.80 |
Enterprise Value | $5.46B | $14.66B |
Dividend Yield | — | 2.86% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKLO trades at $43.31, up 4.94% in the last 24 hours, with a bullish technical signal from moving averages and neutral oscillators. The stock shows significant losses with a net income margin of -12,625.54% and negative cash flow from operations, but strong financing inflows support growth investments. Recent news highlights progress in small modular reactor projects amid sector volatility, with a 52-week low of $36.61 indicating potential support levels.
Outlook: Wall Street consensus is bullish with a $71.58 price target, driven by AI power demand and nuclear energy tailwinds. Risks include project delays, high cash burn, and lack of profitability. The stock offers high growth potential but requires tolerance for execution risk and extended timelines to commercialization.
SNN trades at $27.87, down 3.46% today and near a 52-week low. Technical indicators are bearish, but oversold RSI levels suggest potential for a rebound. Fundamentally, the company shows strong revenue growth to $6.16 billion in 2025 and a net income margin of 10.08%, though recent guidance cuts and CFO departure have weighed on sentiment. A dividend of $0.31 is scheduled for payment in November 2026.
The outlook is cautious due to competitive pressures and execution risks, but valuation metrics like a P/E of 18.96 appear reasonable. Analyst consensus is Hold, with 65% recommending neutrality. Upside depends on improved operational performance and stabilization in key markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
